Comprehensive Hereditary Cancer Panel (190 Genes) Test
Short Name: OncoPro Hereditary Cancer Risk Panel
Also known as: OncoPro Hereditary Cancer Risk Panel, 190 Gene Hereditary Cancer Panel, Comprehensive Cancer Gene Panel, Hereditary Cancer Panel 190 Genes
Comprehensive Hereditary Cancer Panel (190 Genes) Test test available at DNA Labs India for ₹25,000. Uses Next-Generation Sequencing (NGS), Sanger sequencing confirmation on Blood (3-5 ml EDTA) or Buccal Swab samples. Results in Sample collected → transported to ISO-certified lab → NGS and Sanger confirmation → 21-day report delivered digitally via email, WhatsApp, and patient portal.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
This 190-gene panel helps identify inherited pathogenic variants that increase the risk of hereditary cancer syndromes. It supports personalized cancer surveillance, risk-reducing strategies, and informed family planning. The test is suitable for individuals with a strong personal or family cancer history and should be ordered after appropriate genetic counseling.
- Test Code
- 3516
- Price
- ₹25,000
- Sample Type
- Blood (3-5 ml EDTA) or Buccal Swab
- Result Time
- Sample collected → transported to ISO-certified lab → NGS and Sanger confirmation → 21-day report delivered digitally via email, WhatsApp, and patient portal.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS), Sanger sequencing confirmation
Sample Collection
Fasting is not required. Complete the mandatory OncoPro Hereditary Cancer Risk Clinical Information Form (Form 27) before sample submission. Keep government ID and any prior genetic reports available if requested.
Method: Venipuncture or buccal swab
Laboratory Analysis
A phlebotomist will collect 3-5 ml blood in an EDTA tube or a buccal swab. For home collection, the phlebotomist will verify identity and sample labeling.
Report Delivery
No special restrictions are required after sample collection. The sample is transported to the ISO-certified laboratory in a temperature-controlled kit.
Timeline: Sample collected → transported to ISO-certified lab → NGS and Sanger confirmation → 21-day report delivered digitally via email, WhatsApp, and patient portal.
Patient Instructions
About This Test
Who Should Get This Test
This 190-gene panel helps identify inherited pathogenic variants that increase the risk of hereditary cancer syndromes. It supports personalized cancer surveillance, risk-reducing strategies, and informed family planning. The test is suitable for individuals with a strong personal or family cancer history and should be ordered after appropriate genetic counseling.
How to Prepare
- Fill Form 27 completely before sample pickup.
- No fasting is required.
- Choose blood or buccal swab collection as advised.
- Verify sample labeling and patient details at collection.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic testing for hereditary cancer should be accompanied by pre- and post-test counseling. This 190-gene panel is most useful when there is a clear personal or family history of cancer and results must be interpreted with the full clinical picture."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Unlabeled or mislabeled sample
- Missing or incomplete mandatory clinical information Form 27
- Incorrect sample container or insufficient sample volume
- Leaking or damaged sample container
Understanding Your Results
Pathogenic variant detected
Increased risk for the associated hereditary cancer syndrome; clinical management should follow gene-specific guidelines and genetic counseling.
Likely pathogenic variant detected
High probability of increased risk; managed similarly to pathogenic variants while confirmatory family or RNA studies may be advised.
Variant of uncertain significance (VUS)
Unclear clinical significance; not used for clinical decision-making; periodic re-evaluation and family studies may help.
No clinically significant variant detected
Does not eliminate hereditary cancer risk; standard population screening and family history assessment remain important.
Consult your referring doctor or a medical geneticist if a pathogenic or likely pathogenic variant is reported, if you have a strong family history despite a negative result, or if you need help understanding the implications for family members.
Limitations
- ⚠Does not detect all possible genetic alterations, including some deep intronic, regulatory, or large structural variants not covered by the assay.
- ⚠A negative result does not completely eliminate hereditary cancer risk; residual risk remains.
- ⚠Variant interpretation may evolve as new evidence becomes available.
- ⚠Test results are not a cancer diagnosis and must be interpreted by a qualified clinician.
Risks & Considerations
- ●Mild temporary pain or bruising at venipuncture site.
- ●Psychological distress or anxiety related to genetic risk results.
- ●Potential implications for biological family members; pre- and post-test genetic counseling is advised.
Interfering Factors
- ●Missing, incomplete, or inaccurate Form 27 clinical information may compromise interpretation.
- ●Recent allogeneic bone marrow transplant or blood transfusion may affect germline DNA in blood; buccal swab may be preferred.
- ●Variants of uncertain significance require reclassification and should not be used for clinical decision-making.
Compare With Similar Tests
| Test | Comprehensive Hereditary Cancer Panel (190 Genes) Test | ||||
|---|---|---|---|---|---|
| Comparison | Comprehensive Hereditary Cancer Panel (190 Genes) Test |
Frequently Asked Questions
Is fasting required for the OncoPro Hereditary Cancer Risk Panel Test?
What sample type is needed for this test?
How long does it take to get the OncoPro panel report?
Is there an extra charge for home sample collection?
Do you provide genetic counseling to explain the test result?
How can I book the OncoPro Hereditary Cancer Risk Panel Test?
Which genes are covered in this panel?
Who should consider this hereditary cancer panel?
What does a variant of uncertain significance (VUS) mean?
Does a negative test mean I have no cancer risk?
Is this test covered by insurance?
Can this test be done without a doctor prescription?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.